<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1264606" disease_type="Disease or Syndrome" abbrv="">Persistent infection</z:e> with oncogenic <z:e sem="disease" ids="C0850011,C0850009" disease_type="Disease or Syndrome" abbrv="">human papillomavirus</z:e> (HPV) types-16 and -18 is an established cause of cervical and other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Some studies report detection of oncogenic HPV DNA in colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>, with prevalence estimates as high as 84% </plain></SENT>
<SENT sid="2" pm="."><plain>However, other studies report detecting no HPV DNA in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: To evaluate the prevalence of HPV in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> subsets, we conducted a case-case comparison study </plain></SENT>
<SENT sid="4" pm="."><plain>This study included 555 cases of incident <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> from the Seattle <z:hpo ids='HP_0003003'>Colon Cancer</z:hpo> Family Registry (CCFR), ages 20 to 74 years and diagnosed between 1998 and 2002 </plain></SENT>
<SENT sid="5" pm="."><plain>Standardized interviews were used to elicit demographics and risk factor data </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> DNA was assayed for HPV-16 and -18 DNA using real-time PCR </plain></SENT>
<SENT sid="7" pm="."><plain>Microsatellite instability (MSI) status was assessed using a standard 10-marker panel and confirmed with immunohistochemical staining </plain></SENT>
<SENT sid="8" pm="."><plain>Prevalence estimates were calculated for the overall sample, and stratified by patient and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> characteristics </plain></SENT>
<SENT sid="9" pm="."><plain>Fisher exact test was used to compare prevalence between strata </plain></SENT>
<SENT sid="10" pm="."><plain>RESULTS: HPV-16 DNA was detected in 2% of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e>, but no HPV-18 DNA was detected </plain></SENT>
<SENT sid="11" pm="."><plain>HPV-16 prevalence did not vary between cases according to sex, age, race, smoking-status, or MSI-status (P &gt; 0.05) </plain></SENT>
<SENT sid="12" pm="."><plain>HPV-16 prevalence in rectal <z:mp ids='MP_0002038'>carcinomas</z:mp> was 5% compared with 1% in colon <z:mp ids='MP_0002038'>carcinomas</z:mp> (P = 0.03) </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Among a large sample of colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>, prevalence of HPV-16 and -18 was very low </plain></SENT>
<SENT sid="14" pm="."><plain>Prior studies detecting high HPV prevalence in colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> are likely the result of contamination from the anal canal or clinical processing </plain></SENT>
<SENT sid="15" pm="."><plain>Impact: HPV is unlikely to play a large role in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
</text></document>